Hidradenitis Suppurativa

Diagnosis and management.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)

Last reviewed: 21 October 2025

Dermatology

Clinical Guidelines

British Association of Dermatologists guidelines for the management of hidradenitis suppurativa

British Association of Dermatologists guidelines for the management of hidradenitis suppurativa

European S1 guideline for the treatment of hidradenitis suppurativa

European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

NICE guideline [TA392]: Adalimumab for treating hidradenitis suppurativa

NICE guideline [TA935]: Secukinumab for moderate to severe hidradenitis suppurativa

NICE Technology Appraisal Guidance [TA392]

NICE Technology Appraisal Guidance [TA935]

Diagnosis and Treatment of Acne Inversa/Hidradenitis Suppurativa in China: An Expert Consensus Statement (2021 Version)

European S2k guidelines for hidradenitis suppurativa/acne inversa

International consensus statement on the use of ultrasound in hidradenitis suppurativa

Management of hidradenitis suppurativa: an Australasian consensus statement

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement